{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:57:38Z","timestamp":1786132658152,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1681\/asn.2012070713","type":"journal-article","created":{"date-parts":[[2012,12,15]],"date-time":"2012-12-15T20:54:42Z","timestamp":1355604882000},"page":"125-135","source":"Crossref","is-referenced-by-count":91,"title":["Mineral Metabolites and CKD Progression in African Americans"],"prefix":"10.1681","volume":"24","author":[{"given":"Julia J.","family":"Scialla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad C.","family":"Astor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Isakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiliang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-18-20230301","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1097\/01.ASN.0000091586.46532.B4","article-title":"Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.","volume":"14","author":"Hsu","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R4-18-20230301","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans.","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"R5-18-20230301","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/archinte.168.8.832","article-title":"Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.","volume":"168","author":"Appel","year":"2008","journal-title":"Arch Intern Med"},{"key":"R6-18-20230301","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"R7-18-20230301","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2008.4","article-title":"Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease.","volume":"73","author":"Guti\u00e9rrez","year":"2008","journal-title":"Kidney Int"},{"key":"R8-18-20230301","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1097\/01.ASN.0000034202.91413.EB","article-title":"The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease.","volume":"13","author":"De Boer","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R9-18-20230301","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"R10-18-20230301","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ki.2008.64","article-title":"Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease.","volume":"73","author":"Kovesdy","year":"2008","journal-title":"Kidney Int"},{"key":"R11-18-20230301","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: The Heart and Soul Study.","volume":"152","author":"Parker","year":"2010","journal-title":"Ann Intern Med"},{"key":"R12-18-20230301","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","article-title":"Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).","volume":"60","author":"Ix","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R13-18-20230301","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"R14-18-20230301","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R15-18-20230301","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/j.ajkd.2008.06.023","article-title":"Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.","volume":"52","author":"Levin","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R16-18-20230301","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","article-title":"High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients.","volume":"22","author":"Voormolen","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R17-18-20230301","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1681\/ASN.2011020175","article-title":"Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition.","volume":"22","author":"Zoccali","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R18-18-20230301","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2215\/CJN.07810910","article-title":"Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction.","volume":"6","author":"Bellasi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R19-18-20230301","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study.","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R20-18-20230301","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1681\/ASN.2005101101","article-title":"Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease.","volume":"17","author":"Norris","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R21-18-20230301","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial.","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"key":"R22-18-20230301","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1097\/01.ASN.0000070081.15137.C0","article-title":"The rationale and design of the AASK cohort study.","volume":"14","author":"Appel","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R23-18-20230301","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa0910975","article-title":"Intensive blood-pressure control in hypertensive chronic kidney disease.","volume":"363","author":"Appel","year":"2010","journal-title":"N Engl J Med"},{"key":"R24-18-20230301","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial.","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"R25-18-20230301","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/j.ajkd.2011.12.009","article-title":"Longitudinal progression trajectory of GFR among patients with CKD.","volume":"59","author":"Li","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R26-18-20230301","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy.","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"R27-18-20230301","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1172\/JCI109327","article-title":"Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome.","volume":"63","author":"Malluche","year":"1979","journal-title":"J Clin Invest"},{"key":"R28-18-20230301","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/dc11-2235","article-title":"Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease.","volume":"35","author":"Wahl","year":"2012","journal-title":"Diabetes Care"},{"key":"R30-18-20230301","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): A randomised controlled trial.","volume":"376","author":"de Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"R31-18-20230301","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2215\/CJN.02010309","article-title":"Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD.","volume":"4","author":"Agarwal","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R32-18-20230301","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification.","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"R33-18-20230301","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis.","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"R34-18-20230301","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1532-5415.1985.tb07117.x","article-title":"Longitudinal studies on the rate of decline in renal function with age.","volume":"33","author":"Lindeman","year":"1985","journal-title":"J Am Geriatr Soc"},{"key":"R35-18-20230301","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure.","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA"},{"key":"R36-18-20230301","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1001\/archinte.168.20.2212","article-title":"Rapid kidney function decline and mortality risk in older adults.","volume":"168","author":"Rifkin","year":"2008","journal-title":"Arch Intern Med"},{"key":"R37-18-20230301","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia.","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-18-20230301","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ki.2012.82","article-title":"Net endogenous acid production is associated with a faster decline in GFR in African Americans.","volume":"82","author":"Scialla","year":"2012","journal-title":"Kidney Int"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201301000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:22:22Z","timestamp":1786130542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201301000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2012070713","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}